Related Experiment Video

Updated: Aug 16, 2026

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Molecular changes involved in the carcinogenesis of brain tumors

M Debiec-Rychter1, P P Liberski

  • 1Electron Microscopic Laboratory, School of Medicine Lódz.

Folia Neuropathologica
|January 1, 1994
PubMed

Insights

Genetic defects drive brain tumor progression, with p53 gene alterations linked to astrocytic tumors. Glioblastoma often shows chromosome 10 loss and epidermal growth factor receptor (EGFR) gene amplification.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Tumorigenesis involves accumulating genetic defects, leading to malignancy.
  • Primary brain tumors exhibit molecular abnormalities in tumor-suppressor genes, proto-oncogenes, and growth factors.

Purpose of the Study:

  • To investigate genetic alterations in primary brain tumors, focusing on genes like p53 and their role in tumorigenesis.
  • To identify specific genetic changes associated with glioblastoma and other gliomas.

Main Methods:

  • Analysis of tumor-suppressor genes (e.g., p53) and proto-oncogenes.
  • Utilizing Southern blot analysis to detect genetic alterations like gene amplification and loss of heterozygosity.
  • Examining gene expression of growth factors and their receptors.

Main Results:

  • Alterations in the p53 tumor-suppressor gene are associated with astrocytic tumor carcinogenesis.
  • Loss of chromosome 10 (72%) and epidermal growth factor receptor (EGFR) gene amplification (38%) are frequent in glioblastoma.
  • Elevated expression of c-myc, Ha-ras, and c-fos oncogenes increases with glioma malignancy grade.

Conclusions:

  • Multiple genetic defects, including p53 alterations and chromosomal abnormalities, are crucial in brain tumor development and progression.
  • EGFR amplification and chromosome 10 loss are significant molecular events in glioblastoma.
  • Understanding these genetic changes provides insights into glioma pathogenesis and potential therapeutic targets.

More Related Videos

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...